drugset / Trial / NCT00357721
Atazanavir Twice Daily
RandomizedCrossoverOpen-label
Summary
The purpose of this clinical research study is to assess the pharmacokinetics of atazanavir administered twice-daily relative to historical data from atazanavir/ritonavir 300/100 mg, given once daily.
Timeline
- Start
- 2006-06
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atazanavir | Other / unclassified | 200 mg | Oral |
| Comparator | Atazanavir | Other / unclassified | 300 mg | Oral |
| Comparator | Atazanavir | Other / unclassified | 400 mg | Oral |